News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teva Pharmaceutical Industries Limited (TEVA) CEO's 2012 Salary Revealed


7/17/2013 7:31:57 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The salary cost of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) president and CEO Dr. Jeremy Levin was NIS 14.7 million in 2012. His salary was NIS 5.4 million, his annual bonus was NIS 4.3 million, based on the company's profit for the year, and the capital component (the fair value of his stock option grants) was also NIS 4.3 million. Levin has received 450,000 options exercisable at $46 per share, a price that is currently outside the money.

Help employers find you! Check out all the jobs and post your resume.

Read at Globes Online

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES